Market Research Blog – Page 1703 – New Product Development

Global Liquid Amino Ingredients Market Expected to Reach USD 3.63 Billion by 2033, Predicts Future Market Insights Inc.

According to a research analysis from Future Market Insights, the global market for liquid amino Ingredients is expected to be worth US$ 1,861.4 million in 2023 and US$ 3,628.9 million in 2033. Demand for liquid amino ingredients is anticipated to grow globally over the coming ten years at a CAGR of 6.9%.

Liquid formulations with amino acids from marine sources, particularly from marine creatures like fish or seaweed, are referred to as liquid amino ingredients. These liquid amino components are made by extracting amino acids from sources of marine-based protein and converting them into a liquid form for use in a variety of applications.

Request our comprehensive sample report today and gain valuable insights into this thriving industry. https://www.futuremarketinsights.com/reports/sample/rep-gb-17745

Ingredients in liquid amino acids are prized for their distinctive makeup and potential health advantages. They can offer a plentiful source of vital amino acids, including those often present in marine organisms. Glycine, proline, alanine, and arginine are just a few of the typical amino acids that can be found in marine liquid amino components.

The cosmetic and personal care industries use marine liquid amino Ingredients. As they have the potential for moisturizing, nourishing, and skin-repairing effects, some businesses use marine amino acids in the formulations of skincare, hair care, and body care products.

Key Takeaways from the Liquid Amino Ingredients Report:

The global liquid amino ingredients market is expected to reach a valuation of US$ 3,628.9 million by 2033.
Global demand for liquid amino ingredients is likely to soar at 9% CAGR over the forecast period.
Based on Source, the Animal-based segment is anticipated to reach a market share of 0% by 2033.
By Type, the lysine segment is likely to reach a market value of 0% in 2033.
On the basis of the application, the animal feed segment is expected to clock a staggering CAGR of 9%
The United States is projected to hold a dominant value share of 9% in the global market by 2033.
The United Kingdom Liquid amino ingredients market is projected to reach a valuation of US$ 3 million by 2033.
India market is estimated to witness a value CAGR of 7% during the projection period.

“The market for liquid amino Ingredients is growing significantly, in large part as their versatile potential for usage in a variety of industries, including food and beverage, nutraceuticals, pharmaceuticals, and cosmetics. The market is growing as increasing public awareness of the benefits liquid amino Ingredients provide for the health and the rising demand for natural components in these industries. The unique features of Liquid Amino Ingredients”

– says a lead analyst at Future Market Insights (FMI)

Who is Winning?

Ajinomoto Co., Inc., Archer Daniels Midland Company, CJ CheilJedang Corp., Evonik Industries AG, Fufeng Group Company Limited, Kyowa Hakko Bio Co., Ltd., Prinova Group LLC, Sigma-Aldrich Co. LLC, Sunrise Nutrachem Group Co., Ltd., The Lubrizol Corporation

By introducing new products, these companies are focusing on diversifying their product lines. They also employ tactics including marketing, alliances, partnerships, purchases, agreements, and mergers to remain competitive.

For instance,

In 2021, Jarchem Innovative Ingredients announce the addition of four new products to their Aminosyl™ family.
In 2020, The Marquie Group Launching New Amino Acid-Based Products in the Upcoming Launch of the Health and Beauty Solutions Platform.

Get More Valuable Insights

Future Market Insights (FMI) presents historical demand data (from 2018 to 2022) and forecast figures for 2023 to 2033 in its latest offering, offering an independent analysis of the global liquid amino ingredients market.

The study incorporates compelling insights on the liquid amino ingredients market based on Source (Animal-Based, Plant-Based), Type (Lysine, Methionine, Threonine, Tryptophan, Others), By Application (Food & Beverages, Animal Feed, Pharmaceutical & Nutraceutical, Personal Care & Cosmetics, Agriculture, Others)

Ready to tap into the potential of the Liquid Amino Ingredients Market? Get an edge over your competitors with comprehensive insights. Buy now and gain access to detailed segment information. https://www.futuremarketinsights.com/checkout/17745

Liquid Amino Ingredients Market by Category

By Source:

Animal-based
Plant-based

By Type:

Lysine
Methionine
Threonine
Tryptophan
Others

By Application:

Food & Beverages
Animal Feed
Pharmaceutical & Nutraceutical
Personal Care & Cosmetics
Agriculture
Others

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

About the Food & Beverage Division at Future Market Insights (FMI)

The Food and beverage team at Future Market Insights (FMI) assists clients from all over the world with their specific business intelligence requirements through expert analysis, practical insights, and strategic suggestions. The team has spent more than ten years clearly analyzing the food and beverage sector in more than 50+ countries, with a portfolio of more than 1,000 reports and one million+ data points. Contact us to see how we may help if you need end-to-end research and consulting services.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Marine By-products Market Set to Reach USD 64.85 Billion by 2033 Amid Rising Health Ingredient Trends

According to Future Market Insights (FMI), the global marine by-products market is currently valued at US$ 33,725.4 million. Over the forecast period 2023 to 2033, global marine by-product sales are expected to surge at 5.6% CAGR. Total market value at the end of 2033 is anticipated to reach US$ 64,849.3 million.

Growth in the market will be driven by increasing consumer awareness and willingness to pay premiums for high-quality seafood products derived from sustainable sources.

Marine by-products are gaining wider popularity in a wide range of sectors due to their high nutritional content. They are being used in animal feeds, food products, dietary supplements, and cosmetics. Rising production and consumption of these products will therefore boost global marine by-product sales.

Request Your Sample Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-17500

The market is anticipated to benefit from creative promotional strategies and the extraction of useful compounds from underutilized species used by key marine by-product manufacturers.

Manufacturers are implementing creative strategies such as focusing on a variety of marine by-products catering to various end-use segments to minimize dependency on any particular application. It involves producing fish meal and oil for animal feed, aquaculture, and direct human consumption.

Investments are also being made in the development of cost-effective procedures for converting byproducts such as protein concentrates, lipid fractions, and collagen into saleable items.

Producers are looking for strategies to improve yield rates and overall product quality. They are building distribution networks across areas to tap into localized demand, mitigate risks associated with solely concentrating on any single geographic location, and sell surplus inventory into international markets when necessary.

Educating consumers about the benefits and sustainable aspects of marine by-products might also drive market growth. Manufacturers can invest in marketing campaigns, product labeling, and consumer education initiatives to create awareness and promote the value of marine-derived products.

Key Takeaways from the Marine By-products Market Report:

The global marine by-products industry value is anticipated to reach US$ 64,849.3 million by 2033.
Global demand for marine by-products is likely to soar at 6% CAGR over the forecast period.
Based on product type, frozen seafood segment is anticipated to reach a valuation of US$ 54,668.03 million by 2033.
By end use, feed production segment is forecast to reach a valuation of US$ 21,465.14 million by 2033.
The United States marine by-products industry size is projected to reach US$ 15,045.06 million by 2033.
Marine by-product demand in China market is likely to rise at a CAGR of 7%.

“The market for marine by-products is expanding significantly as a result of an increasing need for eco-friendly and sustainable components. To address changing customer tastes and capture opportunities in sectors including food, cosmetics, and nutraceuticals, manufacturers are utilizing modern technology and value-added manufacturing methods. This brings down operating costs, thus providing greater margins to suppliers.” – says Nandini Roy Choudhury, Client Partner at Future Market Insights

Who is Winning?

Copeinca, Pelagia AS, Colpex International, GC Rieber Oils, KD Pharma Group, FF Skagen, Austevoll Seafood ASA, Qingdao Kangjing Marine Biotechnology Co., Ltd., Scanbio Marine Group, Aker BioMarine, Omega Protein Corporation are key marine by-products manufacturers listed in the report.

These key players are expanding their portfolios by introducing new products. They also implement strategies such as partnerships, collaborations, advertisements, acquisitions, and mergers to stay relevant in the market.

Key Companies Profiled

Copeinca
Pelagia AS
Colpex International
GC Rieber Oils
KD Pharma Group
FF Skagen
Austevoll Seafood ASA
Qingdao Kangjing Marine Biotechnology Co., Ltd
Scanbio Marine Group
Aker BioMarine
Omega Protein Corporation

For instance,

In May 2022, Pelagia announced the acquisition of Norsk Fiskeindustri Invest AS (NFI).

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights: https://www.futuremarketinsights.com/checkout/17500

Marine By-products Market by Category

By Product Type:

Frozen Seafood
- Fish
- Molluscs
- Crustaceans
- Others
Fish Oil
- Salmon oil
- Tuna oil
- Cod liver oil
- Sardine oil
- Squalene oil
- Krill oil
- Anchovy oil
- Menhaden oil
- Others
Fish Meal
- Molluscs
- Eels
- Marine fish
- Trout
- Catfish
- Milkfish
- Salmons
- Swordfish
- Tilapia
- Tuna
- Cyprinids
- Crustaceans
- Others

By End Use:

Food Service Industry
Food Processing Industry
Cosmetics
Dietary Supplements
Food and Beverages
Feed Production
Retail / Household

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact FMI:

Gait Trainer Market is expected to be worth USD 456.3 Million, with a projected CAGR of 4.9% By 2028 | FMI

The Gait Trainer Market is experiencing a steady rise, offering crucial support for individuals regaining their mobility. According to a recent analysis by Future Market Insights, the market is projected to reach a value of USD 456.3 million by 2028, reflecting a moderate CAGR (Compound Annual Growth Rate) of 4.9%. This builds on a solid foundation, with the market valued at USD 342.7 million in 2022.

In the year 2021, the exoskeleton market exhibited a total value of USD 4.1 billion, with gait trainer sales contributing 8% to this figure. Notably, gait trainer walkers designed for individuals with cerebral palsy have been gaining traction in recent years, driven by a notable increase in the incidence of cerebral palsy.

Request a Sample Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-2213

Research Methodology

FMI adopts a triangulation methodology to provide accurate and precise market estimations and insights for various medical devices and technologies. This approach primarily relies on patient-level data, the number of procedures, and the capital equipment installation base obtained through experimental techniques. The bottom-up approach is always used to obtain country-specific data and then analyze it to generate global data. This ensures the data’s high quality and accuracy.

In the initial stage, secondary research is conducted to determine the feasibility of the target products/technology categories, segments, product offerings, usage patterns, device lifespan, reimbursement scenarios, adoption rates, and future impact of new technologies. Each piece of information is meticulously analyzed to create a solid foundation for primary research.

Primary research involves the participation of demand-side users, including key opinion leaders, physicians, and surgeons, and supply-side providers of medical devices. These stakeholders provide valuable insights on trends, key treatment patterns, adoption rates, purchasing patterns, technological advancements, patient education, manufacturer effectiveness, pricing, and competitive dynamics. This information is further analyzed throughout the research project to ensure comprehensive and accurate market insights.

To project Year-on-Year (Y-o-Y) growth rates for the market, we conduct a quantitative and qualitative assessment of the fundamental factors driving demand, economic factors and cycles, and growth rates, as well as the strategies used by key players. These Y-o-Y growth projections are adjusted and aligned according to the industry/product lifecycle and utilized to develop holistic market numbers.

Grab Your Discount Now Before It Is Gone!
https://www.futuremarketinsights.com/request-discount/rep-gb-2213

Additionally, we analyze the annual reports, investor presentations, SEC filings, 10k reports, and press releases of various companies operating in this market segment to obtain detailed information on market size, trends, opportunities, drivers, restraints, key players, and their market shares. These key companies are classified into tiers based on their revenue, product portfolio, and market presence.

It’s important to note that these are only the initial steps in developing the market size. In addition to disease-related factors, we use our internal proprietary model for forecasting, which takes into account various macroeconomic factors such as per capita healthcare expenditure, disposable income, industry-based demand driving factors, and their impact on the market forecast trends.

Gait Trainer Market Taxonomy

The Gait Trainer Market has been segmented on the following basis:

End User

Hospitals
Rehabilitation Center
Homecare Setting

Product Type

Gait Trainer Walker
Adult
Pediatric
Treadmill System
Exoskeleton

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Varicella Zoster Infection Treatment Market Is Expected to Grow at an Amazing Rate, Reaching USD 2.04 Billion by 2028, with a CAGR of 4.1%. | FMI

The fight against shingles, a painful reactivation of the chickenpox virus, is gaining traction in the treatment market. The global Varicella Zoster Infection Treatment Market is projected to reach a significant USD 2.5 billion by 2028, reflecting a steady growth of CAGR of 4.1%. This upsurge builds on a market value of over USD 1.61 billion in 2022

Acute varicella may be complicated by secondary bacterial skin infections, cerebellitis, encephalitis, hemorrhagic complications, and viral and bacterial pneumonia. The climate is a core factor that seems to have an impact on the epidemiology of varicella. In most of the temperate climatic regions, 90% of the people are infected before adolescence. In tropical climates, VZV infection occurs later in life and adults are more susceptible to it than children.

On the other hand, herpes zoster or shingles is a sporadic disease that is caused by the reactivation of latent VZV in the sensory nerve ganglia. It is usually self-limiting and is categorized by severe pain with dermatomal distribution and at times followed by post-herpetic neuralgia that can be chronic and debilitating among the geriatric population.

Request a Sample Research Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-6466

Though herpes zoster can occur at any age, most of the cases are reported after the age of 50 along with increasing risks of complications.

To cater to the needs of the patients and provide a potential treatment for this infection, companies are entering into strategic partnerships to make use of the technology of the other leading companies and are also focussing on research and development.

Risk of Varicella in Pregnancy and the Need to Adhere to the Guidelines of Chickenpox Treatment to Bode Well for the Market

Primary infection with varicella zoster in pregnancy may cause maternal mortality or serious morbidity issues. A particular guideline issued in 2015 assesses the evidence regarding maternal and fetal risks of varicella-zoster virus infection in pregnancy. The U.K. Advisory Group and Swiss and Canadian national guidelines prescribe procedures for the use of antiviral drugs in pregnancy. The U.K. Advisory Group provides guidelines for chickenpox as well.

These guidelines recommend oral acyclovir, which should be prescribed for pregnant women within 24 hours once they present the onset of the rash and if they have 20+0 weeks of gestation or beyond. Guidelines are unanimous nevertheless, in recommending that intravenous acyclovir be administered in cases of severe maternal infection. This factor along with the fact that the rate of exposure and transmission is extremely high in this infection and is a threat for pregnant women and kids, is expected to boost the growth of the varicella zoster infection treatment market.

Unbeatable Deals – Claim Your Discount Now.
https://www.futuremarketinsights.com/request-discount/rep-gb-6466

Natural Products to Challenge Market Growth

Several people opt for other treatment options for herpes zoster and varicella. These alternative treatment options are expected to hamper the growth of the antiviral drugs market for varicella zoster infection treatment. Homeopathy, supplements, and other natural herbal medicines are used to treat herpes zoster and varicella.

Varicella Zoster Infection Treatment Market Key Players:

Novartis AG,
Pfizer Inc.,
Abbott Laboratories,
Sun Pharmaceuticals Industries Ltd.,
Valeant Pharmaceuticals International Inc.,
Teva Pharmaceutical Industries Ltd.,
Dr. Reddy’s Laboratories, ltd.,
Mylan N.V. and
GlaxoSmithKline

Access Your Customized Report Today.
https://www.futuremarketinsights.com/customization-available/rep-gb-6466

Varicella Zoster Infection Treatment Market Segmentation – by Category

By Drug Type:

Acyclovir
Valacyclovir
Famciclovir

By Route of Administration:

Oral
Injectable
Topical

By Distribution Channel:

Hospital pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

On-site Preventive Care Market is expected to grow steadily at a 5.2% CAGR and reach USD 43.5 Billion by 2034 | Based on FMI Study

The focus on employee well-being is transforming the way healthcare is delivered. The On-site Preventive Care Market, valued at a substantial USD 26.21 billion in 2024, is experiencing a surge as companies prioritize proactive health management for their workforce.

According to a recent market analysis, this trend is expected to continue, with a projected Compound Annual Growth Rate (CAGR) of 5.2% over the next decade. By 2034, the market is anticipated to reach a remarkable USD 43.52 billion.

Prioritizing Prevention

This surge in demand for on-site preventive care reflects a growing emphasis on maintaining health and well-being before the onset of illness. This proactive approach aligns perfectly with the Human Development Index (HDI) concept, which considers life expectancy a key factor in evaluating a society’s overall development. Businesses are recognizing the benefits of investing in employee health, and on-site preventive care programs offer a convenient and accessible solution for employees.

Request a Sample Copy of the Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-5518

On-site clinics enable employees to receive the required essential care at the time of emergency without having to leave the workplace. The clinicians in these clinics also aid employees in searching for a primary care physician whom they can consult with regularly. As a Future Market Insights analyst quotes, “Changes in lifestyle among the working class have incessantly impelled employers to establish certain behavioural standards within the workplace. This is one of the core factors responsible for the growing adoption of on-site preventive care in several organizations across the globe.”

North America and Western Europe to Compete Neck and Neck

In 2017, North America held a share of 37.0% in the global on-site preventive care market closely trailed by Western Europe. The dominance of North America can be attributed to the several policies implemented by the U.S. government about employee safety and the adoption of certain employee codes of safety. The U.S. is also an extremely mature market owing to the high adoption of workplace wellness programmes.

Burgeoning Penetration of Workplace Wellness Programmes to Bode Well for the Market

In the recent past, workplace wellness programmes have earned the merit of being one of the most adopted healthcare services in the world. It has been further expected that its adoption will increase in the coming years owing to the implementation of the Affordable Care Act. This act is expected to promote an increase in the employee-based coverage of workplace wellness and also promote these programmes through several provisions. Moreover, the growing incidences of chronic diseases among the working population have also become a matter of concern and this has compelled employers across the globe to adopt as well as promote workplace wellness programmes.

Furthermore, employers who have adopted on-site preventive care services have reported enhanced performance ranging from heightened morale and cost savings to productivity. The death of time, access, and cost along with misunderstanding of the benefits of prescribed wellness programmes result in the underutilisation of primary care services. As a result, employees flood emergency rooms, missing out on critical preventive care measures and also leaving chronic conditions unmanaged. In this regard, on-site clinics provide employees with the necessary support without having to leave their work and the clinicians also work together with the patients in a cohesive environment to address their various health-related issues.

Companies to Innovate Services in the On-site Preventive Care Market

To stay ahead of the competition, several companies operating in the global market are focussing on innovating their existing services and integrating new services. Some of the leading companies in the market are Premise Health, OnSite Care, Inc., PrevMED, RepuCare, Healthcare Solutions Centers, LLC, McCormack & Kale Motiva Health & Chiropractic, Inc., Marino Wellness, Kinema Fitness, and TotalWellness.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/5518

Key Segments Covered in On-site Preventive Care Market Research

By Service Type

Acute Care
Chronic Disease Management
Wellness and Coaching
Nutrition Management
Diagnostic and Screening
Others

By Management Model

In-house Management Model
Hybrid Management Model
Outsourced Management Model

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Disposable Negative Pressure Wound Therapy Devices Market is expected to grow at a rate of 10.7% CAGR, or US$461.3 Million, by 2028 | FMI

The way wounds are treated is undergoing a transformation! The Disposable Negative Pressure Wound Therapy Devices Market is experiencing explosive growth, driven by their growing adoption in wound care. According to a recent analysis by Future Market Insights (FMI), a leader in market research, this market is projected to skyrocket from an estimated USD 186.5 million in 2022 to a staggering USD 461.3 million by 2028. This translates to a robust Compound Annual Growth Rate (CAGR) of 10.7%, highlighting the increasing demand for these innovative and convenient wound healing solutions.

In the report published by Future Market Insights titled “Global Disposable Negative Pressure Wound Therapy Devices Industry: Analysis (2017 – 2021) and Opportunity Assessment (2022 – 2028)”, it has been stated that the development around the globe in the last couple of years reflected certain complexities and fissures related to the political environment across many countries.

As protectionists are threatening to penetrate the notions of free trade, globalization is likely to face its most difficult test ever. The threat of populist policies disrupting the decades-old trade agreements has grown bigger as the social and cultural rift between the bourgeoisie and proletariat is deepening with time.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-6348

While the preceding decades were marked by unison and the formation of economic blocks, disintegration has been the story of the recent past. Although the business climate is far from favorable for organizations that have an interest in multiple countries, the prevailing encounters have also obligated that corporate social responsibility becomes more than just a formality and that companies actually demonstrate that they contribute to the societies they operate in.

There is a dire need for companies to participate in discussions and debates that will eventually lead to policy formulations. Owing to these circumstances the Global Disposable Negative Pressure Wound Therapy Devices Industry is anticipated to witness a CAGR of 10.6% over the forecast period of 2022 and 2028.

Cost Control Measures and Rising Healthcare Expenditure to Bode Well for the Market

The adoption rate of disposable NPWT devices is rising in developed nations such as the U.K., Germany, and the U.S., due to the obligation of healthcare burden across these countries owing to the growing prevalence of chronic wounds. According to an article on Wound Practice and Research, the healthcare expenditure for chronic wounds of 6.5 Mn patients accounts for over US$ 25 Bn per year in the U.S. Other research studies have also indicated that among chronic wounds, venous insufficiency ulcers constitute approximately 50% of the chronic leg ulcers. These wounds result from venous etiology.

The annual prevalence of venous insufficiency ulcers in those aged 65 and above has been estimated to be nearly 2 in every 100 persons per year. The prevalence of pressure ulcers varies between 0.31% and 0.70% per year in the United States. Such cases are likely to boost the demand for disposable NPWT in the years to come.

Moreover, the growing focus on the expenditure on healthcare across developed as well as developing nations is expected to drive the adoption high quality patient care treatment options across the globe. This has also led to the rise in the per capita healthcare expenditure owing to the rising disposable income of people across the globe. This is further expected to fuel the demand for wound care therapy and also increase the adoption of disposable NPWT devices in the course of the forecast period.

North America to Lead Among All Regions

North America is expected to stay on the vanguard during the forecast period in the global disposable NPWT devices market with a share of 51.1% in the overall market. The U.S. is expected to emerge as the most lucrative nation in North America closely trailed by Western Europe and Asia Pacific excluding Japan. Based on product type, the market has been bifurcated into disposable NPWT with canisters and disposable NPWT without canisters. Based on end users, the market has been segmented into hospitals, clinics, and home care settings.

Disposable Negative Pressure Wound Therapy Devices Market Players to Concentrate on Product Differentiation

The top players in the market are focusing on product differentiation and expansion of the consumer base to retain their position in the market. The leading players accounted for over 77% of the global market share in 2016. The players are Acelity (Kinetic Concepts, Inc.), Cardinal Health Inc., Smith and Nephew PLC., ConvaTec Inc., and Medela.

Click Here To Purchase Your Detailed Report
https://www.futuremarketinsights.com/checkout/6348

Disposable Negative Pressure Wound Therapy Devices Market Segmentation – by Category

By Product:

Disposable NPWT with canister
Disposable NPWT without canister

By End-user:

Hospitals
Clinics
Home care settings

Region:

North America
Western Europe
Eastern Europe
Latin America
APEJ
Japan
MEA

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Neonatal Thermoregulation Market is Expected to Grow at an Amazing 5.7% CAGR to Reach US$ 1.15 Billion by 2033 | FMI

Ensuring the comfort and well-being of newborns is crucial, and the Neonatal Thermoregulation Market is heating up! This vital industry, valued at USD 661.8 million in 2023, is expected to reach a staggering USD 1.15 billion by 2033. This translates to a promising Compound Annual Growth Rate (CAGR) of 5.7%.

Over the past decade, heightened awareness of neonatal care has been a driving force behind the increased sales of neonatal thermoregulation equipment suppliers worldwide. The upswing in demand from the hospital sector has significantly contributed to this trend. Although the industry experienced a temporary decline during the onset of the COVID-19 pandemic in 2020, there is now a resurgence in momentum as key end-use sectors steadily recover.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5881

The latest revised report on the ‘Neonatal Thermoregulation’ market study by Future Market Insights (FMI) offers an exhaustive overview of the global industry while emphasizing the crucial growth & restraining factors, and demand-supply trajectories across 20+ countries during the forecast period of 2021 to 2031.

Key Takeaways from the Neonatal Thermoregulation Market Study

The global Neonatal Thermoregulation industry is expected to grow at a CAGR of more than 4% through 2031.
High demand for radiant and wall-mounted heaters will drive demand growth.
In terms of modality, the closed segment is expected to have strong demand.
Demand in the hospital sector to fuel sales
The United States continues to be the epicenter of the Neonatal Thermoregulation sector in North America, with Germany remaining at the vanguard of the world’s second-largest Neonatal Thermoregulation industry in Europe.
During the predicted period, Asia Pacific emerged as the fastest-expanding region.
For stakeholders, China, Japan, India, the United Kingdom, France, Italy, Canada, and a few other nations will remain in the spotlight.

“With the growing focus on reducing morbidity and mortality in newborns, the Neonatal Thermoregulation industry is projected to gain further momentum. Furthermore, an increase in several pediatric & neonatal intensive care units is subject to cater to the demand growth shortly,” says an FMI analyst.

Grab Your Report on Discount Before It’s Gone!
https://www.futuremarketinsights.com/request-discount/rep-gb-5881

How is the Increase in Awareness Regarding Newborn Mortality Rates Propelling the Growth?

Thermoregulation plays a very crucial role in balancing heat production and heat loss to maintain the body temperature of newborns within a certain normal range. As not maintaining proper body temperature can be fatal for newborns, demand for Neonatal Thermoregulation is getting prominent in hospitals and neonatal intensive care units.

For instance, neonatal hyperthermia may occur if proper thermoregulation is not done for a newborn. In this condition, the newborn’s body temperature drops below 36.5 degrees Celsius and progressive reduction in body temperature may lead to adverse clinical effects ranging from metabolic stress to death. According to the report titled “Newborns: Improving Survival and Well-Being” published by the World Health Organization (WHO) on 19^th September 2020, globally 2.4 million neonates died in 2019, while approximately 7000 newborns die every day amounting to 47% of all child deaths under the age of 5 years. Such reports are helping in spreading awareness which in turn is favoring Neonatal Thermoregulation equipment suppliers.

Who is Winning in this Space?

The global Neonatal Thermoregulation industry provides with highly competitive environment for key players. To leverage the new opportunities, key players are developing an advanced and wider range of products.

For instance,

General Electric Company launched its new Corometrix 250 cx Series, Corometrics 170 Series Fetal Monitor and Mini Telemetry System, and others during the last 5 years
Natus Medical Incorporated announced the acquisition of Innovative Newborn Care Technology in November 2020 to increase its sales footprint

Some of the key players supplying Neonatal Thermoregulation Market are-

GE Healthcare
Natus Medical Incorporated
Inspiration Healthcare Group Plc.
Koninklijke Philips N.V.
Dragerwerk AG & Co. KGaA
Fisher & Paykel Healthcare
International Biomedical, Ltd
Others

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-5881

Neonatal Thermoregulation Market Segmentation by Category

Product Type

Warmer
- Radiant Warmer
- Wall Mount Warmer
Neonatal Incubators
- Intensive Care Incubator
  - Hybrid Incubator
  - Selective Close Care Incubators
- Transport Incubator
Neonatal Cooling Systems

Modality

Open
Close

End User

Hospitals
Pediatric and Neonatal
- Intensive Care Units
Others

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Prefilled Syringes Drug Molecules Market is expected to grow steadily at a rate of 6% CAGR and reach USD 125 Billion by 2034 | FMI

According to a new analysis by Future Market Insights (FMI), a leading market research firm, the Prefilled Syringes Drug Molecules Market is expected to experience a steady Compound Annual Growth Rate (CAGR) of 6% over the next decade. This translates to a projected market valuation of a staggering USD 125,678 million by 2034, up from USD 70,177.9 million in 2024.

prefilled syringes drug molecules are prefilled with medication by the manufacturers and are supplied to end users in the ready-to-use form. The overall global investment in healthcare has increased in the last few years. Healthcare field solutions continue to be sought after to increase the quality of life, which provides significant opportunities for pharmaceutical companies. This has also contributed to the growth of various segments of the healthcare industry such as the Global Prefilled Syringes Drug Molecules Industry.

Request a Sample Copy of This Report!
https://www.futuremarketinsights.com/reports/sample/rep-gb-3198

Prefilled Syringes Drug Molecules Market: Drivers and Opportunities

The report indicates that the revenue growth of the market is mainly driven by the effectiveness, convenience, and ease of use of prefilled syringes. This has attracted various healthcare professionals and patients to use prefilled syringes. In addition, the minimal contamination of drug molecules and self-administration of drugs at home settings has increased the demand for prefilled syringe drug molecules. Manufacturers are focussing on introducing updated technologies and advanced products to attract customers. Pharmaceutical companies are introducing generic versions for cost-effective auto-injector devices and are targeting emerging regions such as the Asia Pacific, the Middle East, and others to sustain and grow in the Global Prefilled Syringes Drug Molecules Industry.

Prefilled Syringes Drug Molecules Market: Segmental Analysis

Based on region, North America is expected to lead the market with a huge margin. The North American prefilled syringes drug molecules market growing at a CAGR of 6.2% during the forecast period.
Based on drug class, vaccines, and insulin are anticipated to show quite a similar forecast with a high revenue share and CAGR
Based on application, immunization dominates the Global Prefilled Syringes Drug Molecules Industry with its projected revenue share. However, diabetes leads in terms of growth rate with a 6% CAGR during the forecast period.
In terms of end users, hospital pharmacies are expected to lead the global market with a market revenue of over USD 125,678 million by 2034. However, online pharmacies are projected to register a higher growth rate of 6.2% during the forecast period.

Prefilled Syringes Drug Molecules Market: Competitive Landscape

This comprehensive research report consists of a brief profile of all the major players in the industry. Some of the top companies featured in the report are Amgen Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Mylan N.V., Pfizer, Inc., Fresenius Kabi AG, Johnson & Johnson, Sanofi, Merck & Co. Inc., Novartis AG, etc. The Global Prefilled Syringes Drug Molecules Industry is highly competitive due to the presence of well-established top players. However, brands such as EpiPen auto-injector and BD Physioject disposable auto-injector have strategically maintained their position in the market owing to a distinctive value proposition such as providing more precision and accurate dosage.

Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/3198

Key Segments of Prefilled Syringes Drug Molecules Market Research

by Drug Class:

Vaccines
Insulin
Adrenaline
Opioids
Others

By Application:

Prefilled Syringes Drug Molecules for Cardiovascular Diseases
Prefilled Syringes Drug Molecules for Diabetes
Prefilled Syringes Drug Molecules for Immunization
Prefilled Syringes Drug Molecules for Pain Management
Others

By End User:

Prefilled Syringes Drug Molecules Sold at Hospital Pharmacies
Prefilled Syringes Drug Molecules Sold at Retail Pharmacies
Prefilled Syringes Drug Molecules Sold through Online Pharmacies
Prefilled Syringes Drug Molecules Sold at Drug Stores

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Outpatient Clinics Market is expected to reach a milestone of USD 61.4 Billion by 2033, at a staggering 4.2% CAGR | FMI

The healthcare landscape is shifting towards outpatient care, with the Outpatient Clinics Market projected to reach a staggering USD 61.4 billion by 2033. This significant growth is predicted by Future Market Insights (FMI), a leading industry analyst.

Fueled by a growing preference for accessible and cost-effective healthcare, the outpatient clinic industry is experiencing a surge. In 2023, the market is already valued at a substantial USD 40.8 billion, and it’s expected to maintain a consistent CAGR (Compound Annual Growth Rate) of 4.2% throughout the forecast period.

Outpatient clinics, also called ambulatory care centers, have emerged as central contributors in delivering a diverse range of medical services, diagnostic tests, and treatments without the need for overnight hospitalization. This transformative shift in healthcare delivery seamlessly aligns with the escalating global demand for convenient and efficient healthcare solutions.

Growing advancements in medical technology have led to the development of treatment techniques and medications that do not require patients to stay for long hours at clinics or hospitals.

However, the imposition of strict regulations will continue to hinder the global market growth of outpatient disorders over the forecast period.

Future Market Insights states that the global market of outpatient clinics is projected to reflect a CAGR of 4.3%, representing more than US$ 39,000 Mn by 2022-end.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5697

Factors Fuelling Outpatient Clinics Market Growth

Growth of the Global Outpatient Clinics Industry is mainly bound to various macro-economic and micro-economic factors.
The prevalence of chronic diseases such as asthma, diabetes, depression, and congestive heart failure leads to complex and severe health problems.
With the escalating cost of the treatment process in various healthcare organizations, patients prefer visiting outpatient clinics to access treatment.
Growing concerns regarding the increasing prevalence of cardiovascular diseases such as elevated blood pressure levels, hypertension, coronary heart diseases, and cerebrovascular diseases have further led to a surge in demand for outpatient clinics globally.
Demand for quick and effective treatment of cardiovascular diseases will continue contributing to the global market growth of outpatient disorders.
According to a recently published report by the CDC, nearly 610,000 people die of heart attack in the U.S. each year, which is 1 in every 4 deaths.
As cardiovascular diseases continue to remain a leading cause of mortality globally, demand for effective and quick treatment processes will continue to remain high.
These factors are projected to impact the global market growth of outpatient clinics throughout the forecast period.
Collaborations among private insurance companies and outpatient clinics will continue to remain a major trend in the global market.
Through collaborations, private insurance companies offer payment and services in outpatient clinics.
Imposition of regulations such as the Health Care and Educational Reconciliation Act and Patient Care Affordable Act provides U.S. citizens with public health insurance coverage and offers access to private health insurance services.
Moreover, increasing employee benefits such as Employees’ health insurance by employers is projected to contribute towards the global market growth of outpatient clinics over the forecast period.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-5697

However, the Global Outpatient Clinics Industry of outpatient clinics will continue to witness inhibiting growth attributed to various factors.

The imposition of strict regulations and a limited number of doctors for the treatment of various diseases will remain a key factor inhibiting demand for services offered by outpatient clinics.

As the patients are not monitored for a long period, the risk of addiction to alcohol and drugs is projected to remain high.

Moreover, the lack of access to counselors in comparison to the residential and inpatient facilities is further projected to impede the global market growth of outpatient clinics.

Sales to Remain High Through Cardiology Specialty Areas

The prevalence of chronic and cardiovascular disorders is projected to fuel demand for multi-specialty centers globally.

In terms of revenue, the multi-specialty center type segment is projected to witness significant growth, representing more than US$ 8,400 Mn by 2022-end.

Moreover, the multi-specialty center type segment is projected to reflect the fastest growth in the global market of outpatient clinics throughout the forecast period.

Based on specialty type, the dermatology segment is projected to reflect a significant CAGR through 2022.

However, the cardiology specialty areas segment is projected to represent a robust revenue growth, recording more than US$ 3,000 Mn over the forecast period.

Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/5697

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Blood Warmer Devices Market is expected to grow at a 7.6% CAGR and reach USD 937.5 million by 2032 | FMI Study

The Blood Warmer Devices Market is experiencing a significant temperature rise! According to a new report by Future Market Insights (FMI), the global blood warmer devices market is projected to reach a scorching USD 937.5 million by 2032. This substantial growth is fueled by a steady Compound Annual Growth Rate (CAGR) of 7.6%, building on a current market value of USD 451.2 million in 2022.

Among the key findings, intravenous warming systems have emerged as the market leader, claiming a substantial market share of 47.1% in 2021. FMI’s comprehensive report provides a detailed trajectory analysis of the industry, offering invaluable insights into crucial market drivers, trends, and challenges.

According to the FMI study, the Global Blood Warmer Devices Industry is on track for consistent growth, projecting a 5.0% CAGR from 2017 to 2026. By the conclusion of 2026, the market is estimated to generate an impressive US$ 223.5 million in revenue. The escalating prevalence of trauma incidents, bypass surgeries, thyroid and orthopedic surgeries, coupled with the rising cases of diabetes, is propelling the adoption of blood-warming devices. These devices play a pivotal role in the treatment and prevention of complications such as hemorrhage and hypothermia.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5685

Hypothermia has become very common and causes major complications, this is driving the demand for blood warmer devices. Since these devices can help in preventing complications during the blood transfusion process the demand is expected to grow in the future. Companies are also investing in the research and development of portable and smart blood-warming devices. Manufacturers are also working on new business strategies to launch a new product. Partnerships and collaborative activities are also on the rise. The demand for disposable blood and fluid warmer devices is also increasing, due to the rise in some complications.

Key Market Players Competing to Sustain in the Market

The report offers a detailed profile of some of the key market players in the Global Blood Warmer Devices Industry such as 3M Company, Smiths Medical, The 37 Company, GE Healthcare, Emit Corporation, Stryker Corporation, Geratherm Medical, Barkey GmbH & Co. KG, Stihler Electronic GmbH, Biegler GmbH, Belmont Instrument, Keewell Medical Technology Co. Ltd., and Baxter International Inc. (Gambro). These key players are continuously working on new business strategies to offer better products and compete in the global market.

Forecast Highlights on the Blood Warmer Devices Market

The Global Blood Warmer Devices Industry is segmented based on end-user, product type, application, and region. Based on the product type, the segment includes intravenous warming systems, surface warming systems,s, and blood warming accessories. Among these, surface warming system is expected to be the widely accepted product in the global blood-warmer devices market. By the end of 2026, the surface warming system is estimated to surpass US$ 100 million in revenue.

Based on end users, the segmentation consists of hospitals, blood banks, home care settings, and others. Hospitals are expected to be the largest users of blood warmer devices. By the end of 2017, hospitals are estimated to account for nearly two-thirds of the revenue share.

Based on the application, the market is segmented into home care, preoperative care, acute care, newborn care, and other applications. Blood warming devices are expected to find the largest application in preoperative care. By the end of 2026, the preoperative care segment is estimated to reach nearly US$ 100 million in revenue.

Geographically, the market is segmented into Europe, North America, Japan, Asia Pacific Excluding Japan (APEJ), the Middle East and Africa (MEA), and Latin America. Among these, North America is expected to dominate the Global Blood Warmer Devices Industry during the forecast period 2017-2026. The increasing occurrence of hypothermia among the aging population and infants in the U.S. is one of the factors driving the growth in North America. Growth in trauma cases and surgeries is also contributing to the growth of the market in the region.

Click Here To Purchase Your Detailed Report
https://www.futuremarketinsights.com/checkout/5685

Blood Warmer Devices Market Taxonomy

Region

North America
Latin America
Europe
Japan
APEJ
MEA

Product Type

Intravenous Warming System
Surface Warming System
Blood Warming Accessories

End User

Hospitals
Blood Banks
Home Care Settings
Other End Users

Application

Preoperative Care
Home Care
Acute Care
New Born Care
Other Applications

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube